Biological Image-guided Radiotherapy in Rectal Cancer: Challenges and Pitfalls

Roels, Sarah;Slagmolen, Pieter;Nuyts, Johan;Lee, John;Haustermans, Karin;et.al.
(2009) International Journal of Radiation: Oncology - Biology - Physics — Vol. 75, n° 3, p. 782-790 (2009)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 823.49 KB

Details

Authors
  • Roels, SarahUCLouvain
    Author
  • Slagmolen, PieterUCLouvain
    Author
  • Nuyts, JohanUCLouvain
    Author
  • Lee, Johnorcid-logoUCLouvain
    Author
  • Loeckx, DirkUCLouvain
    Author
  • Maes, FrederikUCLouvain
    Author
  • Vandecaveye, VincentUCLouvain
    Author
  • Stroobants, SigridUCLouvain
    Author
  • Ectors, NadineUCLouvain
    Author
  • Penninckx, FreddyUCLouvain
    Author
  • Haustermans, KarinUCLouvain
    Author
Show more
Abstract
Purpose: To investigate the feasibility of integrating multiple imaging modalities for image-guided radiotherapy in rectal cancer. Patients and Methods: Magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) were performed before, during, and after preoperative chemoradiotherapy (CRT) in patients with resectable rectal cancer. The FDG-PET signals were segmented with an adaptive threshold-based and a gradient-based method. Magnetic resonance tumor volumes (TVs) were manually delineated. A nonrigid registration algorithm was applied to register the images, and mismatch analyses were carried out between MR and FDG-PET TVs and between TVs over time. Tumor volumes delineated on the images after CRT were compared with the pathologic TV. Results: Forty-five FDG-PET/CT and 45 MR images were analyzed from 15 patients. The mean MRI and FDG-PET TVs showed a tendency to shrink during and after CRT. In general, MRI showed larger TVs than FDG-PET. There was an approximately 50% mismatch between the FDG-PET TV and the MRI TV at baseline and during CRT. Sixty-one percent of the FDG-PET TV and 76% of the MRI TV obtained after 10 fractions of CRT remained inside the corresponding baseline TV. On MRI, residual tumor was still suspected in all 6 patients with a pathologic complete response, whereas FDG-PET showed a metabolic complete response in 3 of them. The FDG-PET TVs delineated with the gradient-based method matched closest with pathologic findings. Conclusions: Integration of MRI and FDG-PET into radiotherapy seems feasible. Gradient-based segmentation is recommended for FDG-PET. Spatial variance between MRI and FDG-PET TVs should be taken into account for target definition. (C) 2009 Elsevier Inc.
Affiliations

Citations

Roels, S., Slagmolen, P., Nuyts, J., Lee, J., Loeckx, D., Maes, F., Vandecaveye, V., Stroobants, S., Ectors, N., Penninckx, F., & Haustermans, K. (2009). Biological Image-guided Radiotherapy in Rectal Cancer: Challenges and Pitfalls. International Journal of Radiation: Oncology - Biology - Physics, 75(3), 782-790. https://doi.org/10.1016/j.ijrobp.2008.11.031 (Original work published 2009)